0.00Open0.00Pre Close0 Volume0 Open Interest250.00Strike Price0.00Turnover0.00%IV-42.39%PremiumNov 15, 2024Expiry Date74.42Intrinsic Value100Multiplier0DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma--Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Alphabet-A Stock Discussion
Hugely Undervalued $2 Biotech With 21% Held Short $16 Price Target, Takeover Candidate, Soon Profitable. Fund that owns $Viking Therapeutics (VKTX.US)$ since 2022 below $10 a share is also investing in ESPR and expects the company will be a block buster.
This unique biotech $Esperion Therapeutics (ESPR.US)$ Esper...
With the S&P500 going up between 2.2% to 3.8% on average, over last 10 and 20 years in the month. Australia’ market has generally only risen between 0.5% and 1.8% on average in November. But this month, markets have had a cracker, and are already up 4.3% in the US. And 1.5% in Australia. Markets are trading around record all time highs...
https://youtu.be/HiqIvubII0o
No comment yet